Rossmore Private Capital - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 2 filers reported holding HISTOGENICS CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rossmore Private Capital ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q2 2019$46,000
+64.3%
242,0040.0%0.02%
+60.0%
Q1 2019$28,000
+33.3%
242,0040.0%0.01%
+11.1%
Q4 2018$21,000
+250.0%
242,004
+2053.8%
0.01%
+350.0%
Q3 2018$6,000
-78.6%
11,2360.0%0.00%
-88.9%
Q2 2018$28,000
-9.7%
11,2360.0%0.02%
-41.9%
Q1 2018$31,000
-99.9%
11,2360.0%0.03%
+34.8%
Q4 2017$23,034,00011,2360.02%
Other shareholders
HISTOGENICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
S Squared Technology, LLC 1,169,387$2,923,0002.32%
Abingworth LLP 888,889$2,204,0001.26%
Sofinnova Investments, Inc. 4,154,080$10,386,0000.66%
Third Security, LLC 2,690,570$6,726,0000.54%
Archon Capital Management LLC 293,090$733,0000.23%
Perceptive Advisors 2,203,277$5,508,0000.14%
Endurant Capital Management LP 56,177$140,0000.06%
Sio Capital Management, LLC 39,175$98,0000.05%
Palo Alto Investors LP 302,922$757,0000.03%
Rossmore Private Capital 11,236$28,0000.02%
View complete list of HISTOGENICS CORP shareholders